Dietary ganglioside inhibits acute inflammatory signals in intestinal mucosa and blood induced by systemic inflammation of Escherichia coli lipopolysaccharide

Shock

Volumn 28, Issue 1, 2007, Pages 112-117

  Park, Eek Joong ^a   Suh, Miyoung ^a   Thomson, Benjamin ^a   Ma, David W L ^b   Ramanujam, Kalathur ^c   Thomson, Alan B R ^a   Clandinin, Michael Tom ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PFIZER INC   (United States)

Author keywords

Diet; Ganglioside; Infection; Inflammation; Intestine; Lipopolysaccharide

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHOLESTEROL; ENDOTOXIN; GANGLIOSIDE; INTERLEUKIN 1BETA; LEUKOTRIENE B4; PROSTAGLANDIN E2; SODIUM CHLORIDE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BLOOD SAMPLING; CONTROLLED STUDY; ENTERITIS; ESCHERICHIA COLI; INFLAMMATION; INTESTINE MUCOSA; MALE; NONHUMAN; RAT; SPRAGUE DAWLEY RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; CHOLESTEROL; DIETARY FATS; DINOPROSTONE; GANGLIOSIDES; INFLAMMATION; INTERLEUKIN-1BETA; INTESTINAL MUCOSA; LEUKOTRIENE B4; LIPOPOLYSACCHARIDES; MALE; MEMBRANE MICRODOMAINS; PLATELET ACTIVATING FACTOR; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34250692041     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3180310fec     Document Type: Article

References (37)

1. Ledeen RW: Biology of gangliosides: neuritogenic and neuronotrophic properties. J Neurosci Res 12:147-159, 1984.
2. Singh AK, Harrison SH, Schoeniger JS: Gangliosides as receptors for biological toxins: development of sensitive fluoroimmunoassays using ganglioside-bearing liposomes. Anal Chem 72:6019-6024, 2000.
3. Takamizawa K, Iwamori M, Mutai M, Nagai Y: Selective changes in gangliosides of human milk during lactation: a molecular indicator for the period of lactation. Biochim Biophys Acta 879:73-77, 1986.
4. Vanier MT, Holm M, Ohman R, Svennerholm L: Developmental profiles of gangliosides in human and rat brain. J Neurochem 18:581-592, 1971.
5. Bouhours D, Bouhours JF: Developmental changes of hematoside of rat small intestine. Postnatal hydroxylation of fatty acids and sialic acid. J Biol Chem 258:299-304, 1983.
6. Rueda R, Puente R, Hueso P, Maldonado J, Gil A: New data on content and distribution of gangliosides in human milk. Biol Chem Hoppe Seyler 376:723-727, 1995.
7. Perkkio M, Savilahti E: Time of appearance of immunoglobulin-containing cells in the mucosa of the neonatal intestine. Pediatr Res 14:953-955, 1980.
8. Rueda R, Sabatel JL, Maldonado J, Molina-Font JA, Gil A: Addition of gangliosides to an adapted milk formula modifies levels of fecal Escherichia coli in preterm newborn infants. J Pediatr 133:90-94, 1998.
9. Colarow L, Turini M, Teneberg S, Berger A: Characterization and biological activity of gangliosides in buffalo milk. Biochim Biophys Acta 1631:94-106, 2003.
10. Yang HC, Farooqui AA, Horrocks LA: Effects of glycosaminoglycans and glycosphingolipids on cytosolic phospholipases A2 from bovine brain. Biochem J 299(pt 1):91-95, 1994.
11. Basavarajappa BS, Saito M, Cooper TB, Hungund BL: Activation of arachidonic acid-specific phospholipase A2 in human neuroblastoma cells after chronic alcohol exposure: prevention by GM1 ganglioside. Alcohol Clin Exp Res 21:1199-1203, 1997.
12. Fukushima T, Serrero G: Characterization of calcium-independent cytosolic phospholipase A2 activity in the submucosal regions of rat stomach and small intestine. Lipids 29:163-169, 1994.
13. Park EJ, Suh M, Ramanujam K, Steiner K, Begg D, Clandinin MT: Diet-induced changes in membrane gangliosides in rat intestinal mucosa, plasma and brain. J Pediatr Gastroenterol Nutr 40:487-495, 2005.
14. Park EJ, Suh M, Thomson B, Thomson AB, Ramanujam KS, Clandinin MT: Dietary ganglioside decreases cholesterol content, caveolin expression and inflammatory mediators in rat intestinal microdomains. Glycobiology 15:935-942, 2005.
15. Orlandi PA, Fishman PH: Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol 141:905-915, 1998.
16. Triantafilou M, Miyake K, Golenbock DT, Triantafilou K: Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci 115:2603-2611, 2002.
17. Olson NC, Joyce PB, Fleisher LN: Role of platelet-activating factor and eicosanoids during endotoxin-induced lung injury in pigs. Am J Physiol 258:H1674-H1686, 1990.
18. Peplow PV, Mikhailidis DP: Platelet-activating factor (PAF) and its relation to prostaglandins, leukotrienes and other aspects of arachidonate metabolism. Prostaglandins Leukot Essent Fatty Acids 41:71-82, 1990.
19. Poubelle PE, Gingras D, Demers C, Dubois C, Harbour D, Grassi J, Rola-Pleszczynski M: Platelet-activating factor (PAF-acether) enhances the concomitant production of tumour necrosis factor-alpha and interleukin-1 by subsets of human monocytes. Immunology 72:181-187, 1991.
20. Clandinin MT, Yamashiro S: Effects of methionine supplementation on the incidence of dietary fat induced myocardial lesions in the rat. J Nutr 110:1197-1203, 1980.
21. Martinez FE, Reno C, Trevenen CL, Hart DA, Belik J: Age-dependent changes in the regulation of cyclooxygenases in the gastrointestinal tract after gram-negative endotoxemia. J Pediatr Gastroenterol Nutr 33:165-170, 2001.
22. Jumpsen JA, Lien EL, Goh YK, Clandinin MT: During neuronal and glial cell development diet n-6 to n-3 fatty acid ratio alters the fatty acid composition of phosphatidylinositol and phosphatidylserine. Biochim Biophys Acta 1347:40-50, 1997.
23. Folch J, Lees M, Sloane-Stanley GH: A simple method for the isolation and purification of total lipids from animal. J Biol Chem 226:497-509, 1957.
24. Williams MA, McCluer RH: The use of Sep-Pak C18 cartridges during the isolation of gangliosides. J Neurochem 35:266-269, 1980.
25. Suzuki K: A simple and accurate micromethod for quantitative determination of ganglioside patterns. Life Sci 3:1227-1233, 1964.
26. Itoh T, Kanmura Y, Kuriyama H: Inorganic phosphate regulates the contraction-relaxation cycle in skinned muscles of the rabbit mesenteric artery. J Physiol 376:231-252, 1986.
27. Nieto N, Fernandez MI, Torres MI, Rios A, Suarez MD, Gil A: Dietary monounsaturated n-3 and n-6 long-chain polyunsaturated fatty acids affect cellular antioxidant defense system in rats with experimental ulcerative colitis induced by trinitrobenzene sulfonic acid. Dig Dis Sci 43:2676-2687, 1998.
28. Rosengren S, Firestein GS, Boyle DL: Measurement of inflammatory biomarkers in synovial tissue extracts by enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 10:1002-1010, 2003.
29. Memon RA, Grunfeld C, Moser AH, Feingold KR: Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology 132:2246-2253, 1993.
30. Wallace JL, Steel G, Whittle BJ, Lagente V, Vargaftig B: Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists. Gastroenterology 93:765-773, 1987.
31. Koumanov KS, Quinn PJ, Bereziat G, Wolf C: Cholesterol relieves the inhibitory effect of sphingomyelin on type II secretory phospholipase A2. Biochem J 336(pt 3):625-630, 1998.
32. Dubois C, Bissonnette E, Rola-Pleszczynski M: Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors. J Immunol 143:964-970, 1989.
33. Wallace JL, Whittle BJ: Effects of inhibitors of arachidonic acid metabolism on Paf-induced gastric mucosal necrosis and haemoconcentration. Br J Pharmacol 89:415-422, 1986.
34. Rola-Pleszczynski M, Lemaire I: Leukotrienes augment interleukin 1 production by human monocytes. J Immunol 135:3958-3961, 1985.
35. Tjoelker LW, Stafforini DM: Platelet-activating factor acetylhydrolases in health and disease. Biochim Biophys Acta 1488:102-123, 2000.
36. Anthonsen MW, Solhaug A, Johansen B: Functional coupling between secretory and cytosolic phospholipase A2 modulates tumor necrosis factor-alpha-and interleukin-1beta-induced NF-kappa B activation. J Biol Chem 276:30527-30536, 2001.
37. Ziegler-Heitbrock HW, Kafferlein E, Haas JG, Meyer N, Strobel M, Weber C, Flieger D: Gangliosides suppress tumor necrosis factor production in human monocytes. J Immunol 148:1753-1758, 1992.